Athina Kilpelainen

Publicacions destacades

• Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice

  Autors:

  Kilpelainen, Athina; Saubi, Narcis; Guitart, Noria; Moyo, Nathifa; Wee, Edmund G.;

  Ravi, Krupa; Hanke, Tomas; Josep, Joan.

  Referència: FRONT IMMUNOL.

• Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: Lessons learned

  Autors:

  Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J;

  Referència: EXPERT REVIEW OF VACCINES.

• Recombinant BCG: tHIVconsvX Prime-ChAdOx: tHIVconsvX Boost Regimen Was Safe, Stable and Elicited Specific HIV-1 T-cell Immune Responses in BALB/C Mice

  Autors:

  Kilpelainen, Athina; Saubi, Narcis; Guitart, Nuria; Moyo, Nathifa; Hanke, Tomas;

  Joseph, Joan;.

  Referència: AIDS RESEARCH AND HUMAN RETROVIRUSES.

• Construction and Characterization of Recombinant MTBVAC. HIV, a New Live Attenuated Vaccine Against HIV and Tuberculosis

  Autors:

  Saubi, Narcis; Broset, Esther; Guitart, Nuria; Aguilo, Nacho; Uranga, Santiago;

  (...)

  Eto, Yoshiki; Hanke, Tomas; Gonzalo-Asensio, Jesus; Martin, Carlos; Joseph, Joan;.

  Veure llistat complet d'autors

  Referència: AIDS RESEARCH AND HUMAN RETROVIRUSES.